Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9HC10: Variant p.Pro490Gln

Otoferlin
Gene: OTOF
Feedback?
Variant information Variant position: help 490 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Proline (P) to Glutamine (Q) at position 490 (P490Q, p.Pro490Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (P) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In DFNB9. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 490 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1997 The length of the canonical sequence.
Location on the sequence: help QKSSYEPLWNEQVVFTDLFP P LCKRMKVQIRDSDKVNDVAI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         QKSSYEPLWNEQVVFTDLFPPLCKRMKVQIRDSDKVNDVAI

Mouse                         QKSSYEPLWNEQVVFTDLFPPLCKRMKVQIRDSDKVNDVAI

Rat                           QKSSYEPLWNEQVVFTDLFPPLCKRMKVQIRDSDKVNDVAI

Zebrafish                     QKSSYEPIWNEQVIFTEMFPPLCRRLKVQIRDSDKVNDVAI

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1997 Otoferlin
Topological domain 1 – 1963 Cytoplasmic
Domain 400 – 531 C2 3
Alternative sequence 1 – 747 Missing. In isoform 2 and isoform 4.
Alternative sequence 1 – 690 Missing. In isoform 3.



Literature citations
Substitutions in the conserved C2C domain of otoferlin cause DFNB9, a form of nonsyndromic autosomal recessive deafness.
Mirghomizadeh F.; Pfister M.; Apaydin F.; Petit C.; Kupka S.; Pusch C.M.; Zenner H.P.; Blin N.;
Neurobiol. Dis. 10:157-164(2002)
Cited for: VARIANTS DFNB9 GLN-490 AND THR-515; OTOF mutations revealed by genetic analysis of hearing loss families including a potential temperature sensitive auditory neuropathy allele.
Varga R.; Avenarius M.R.; Kelley P.M.; Keats B.J.; Berlin C.I.; Hood L.J.; Morlet T.G.; Brashears S.M.; Starr A.; Cohn E.S.; Smith R.J.H.; Kimberling W.J.;
J. Med. Genet. 43:576-581(2006)
Cited for: VARIANTS DFNB9 GLN-490; HIS-794 AND ALA-1825; VARIANTS AUNB1 THR-515; PRO-1011; GLN-1939 AND ARG-1987; VARIANTS VAL-53; CYS-82; MET-575; SER-773; TRP-822; PRO-1083; GLN-1157; GLU-1322; MET-1625; SER-1646 AND ASP-1888;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.